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Introduction
The success of gene therapy is largely dependent on the development of a vector which can selectively and efficiently deliver a gene to target cells with minimal toxicity. 1 Cationic lipidic vectors, although relatively safe and weakly immunogenic, are less efficient than viral vectors. 2, 3 Current efforts in improving lipidic vectors are mainly based upon the study of the structure-function relationship of cationic lipids [4] [5] [6] and upon an improved understanding of cellular and molecular barriers for in vitro lipofection. [7] [8] [9] Little is understood about the mechanism of in vivo lipofection. It is known that the in vivo performance of a lipidic vector depends on administration routes. A formulation suitable for intratissue injection, such as intratumor administration, may not work when administered intravenously and vice versa. This is mainly due to the difference in the biological environment that the vector encounters. With different administration routes, the lipidic vectors might be modi-fied differently by biological fluids before they reach target cells. Understanding of the barrier for in vivo lipofection via different administration routes is, therefore, critical for the development of a suitable gene delivery vector.
Recently, several studies have shown that intravenous administration of cationic liposome/DNA complex (lipoplex) 10 or cationic liposome/polycation/DNA complex (lipopolyplex) 10 gives systemic gene expression, particularly in the lung. [11] [12] [13] [14] [15] [16] [17] [18] [19] Several parameters have been identified to be important for achieving a high level of gene expression in vivo such as the structure of cationic lipids, the charge ratio (+/−) between the cationic lipid and DNA, 15, 16 and the size of liposomes. 12 The choice of a helper lipid also plays an important role in determining the in vivo activity of lipidic vectors. [12] [13] [14] Particularly, when dioleoylphosphatidylethanolamine (DOPE) is used as a helper lipid, the in vivo activity of lipidic vectors decreases by 100-to 1000-fold, while inclusion of cholesterol significantly enhances the in vivo activity of lipidic vectors. [12] [13] [14] This is in contrast to intratracheal or intratissue administration of lipidic vectors where DOPE enhances in vivo lipofection. These studies suggest that optimization of lipidic vectors needs to be individualized with different administration routes. However, little is understood at present about how different helper lipids affect the interaction of lipidic vectors with serum, and the mechanism by which lipidic vectors transfect cells in vivo. In order to understand the mechanism of in vivo lipofection by intravenous administration, we have studied how serum affects the biophysical and biological properties of lipidic vectors. Our previous study showed that lipidic vectors became negatively charged after exposure to mouse serum and that there was a significant increase in the size of lipidic vectors. 20 Also, cationic lipidic vectors recruited large amounts of serum proteins, particularly those containing DOPE as a helper lipid. 20 In this study, we found that further interactions of lipidic vectors with serum led to disintegration of lipidic vectors, DNA release and degradation. The rate of vector disintegration is largely dependent on lipid composition. A vector with a rapid rate of disintegration poorly transfects cells in vivo. These studies have important implications in developing a lipidic vector for intravenous lipofection.
Results
Dynamic changes in the turbidity of lipidic vectors after exposure to mouse serum Figure 1a shows the turbidity of lipopolyplexes at different times after exposure to mouse serum. Lipopolyplexes containing different helper lipids were mixed with mouse serum at a ratio of 1:2 (v/v). To mimic the in vivo situation, the mixtures were incubated at 37°C with gentle shaking. Addition of lipopolyplexes into serum resulted in an immediate increase in turbidity, suggesting that lipidic vectors formed aggregates. The DOPE-containing lipopolyplexes were the most turbid while those that did not have any helper lipid were the least turbid. The initial, slow increase in turbidity for the latter formulation might be partly due to the lower amount of total lipid in the mixture; increasing the dose of DOTAP lipid resulted in a significant increase in its turbidity (data not shown). Further interaction of lipopolyplexes with serum was then associated with a decrease in turbidity. Yet, the rate of decrease in turbidity was greatly dependent on the helper lipid. The DOPE-containing formulation had a rapid rate of decrease in turbidity, the mixture became completely clear at about 2-3 h of incubation while the other two formulations remained turbid for a relatively long period of time.
A similar result was obtained when lipoplexes were used (Figure 1b) . Addition of empty liposomes into serum also resulted in an increase in turbidity, but the rate of subsequent decrease in turbidity is much faster than that of lipopolyplexes or lipoplexes (Figure 1c) .
Incubation of cationic lipidic vectors in 5% dextrose at 37°C did not result in aggregation of vectors. Addition of PBS into lipidic vectors may trigger vector aggregation, but further incubation at 37°C did not lead to disaggregation (data not shown).
Sucrose density gradient centrifugation profile of lipopolyplexes at different times after exposure to mouse serum Untreated lipopolyplexes exhibit as a heterogeneous population in a 30-20-10-0% discontinuous gradient. 20 After exposure to mouse serum, lipopolyplexes formed aggregates which exhibited as a single band containing most of the input lipids and DNA (Figure 2 ). Further interaction of lipopolyplexes with serum resulted in a gradual decrease of the major peak and at the same time, more and more DNA was found in serum fractions which were located at a lower portion of the gradient. Similar results were obtained when 3 H-DPPC was used as a label (data not shown). Again, the rate in the decrease of major peak was dependent on the helper lipid. The order of rate was DOPE ϾϾcholesterol Ͼno helper lipid. The fact that all of the DNA and lipid labels in DOPE formulations were found in serum fractions 3 h after incubation with serum suggested that lipidic vectors were completely disassembled. A likely possibility is that lipids in the vectors were extracted by serum proteins.
Ultrastructure of lipopolyplexes before and after exposure to mouse serum We examined the ultrastuctural characteristics of DOPEcontaining lipopolyplexes as a result of serum treatment by using freeze-fracture electron microscopy ( Figure 3) . Lipopolyplexes before or 5 min after exposure to serum were purified by sucrose density gradient centrifugation. Pre-treated lipopolyplexes were consistently observed as single particles throughout the replica and were 50-100 nm in diameter. After incubation in mouse serum, the lipopolyplexes coalesced to form heterogeneous aggregates, fused to form large lipopolyplexes and in some instances displayed compromised integrity, indicating partial solubilization of the bilayer structure. Also of note are the changes in the surface of the lipopolyplexes where a smooth, uniform surface appeared to become rough and textured with serum treatment, indicating surface modification by serum components. Similar pictures were found for lipopolyplexes that either contained cholesterol as a helper lipid or did not have any helper lipid (data not shown). Unfortunately, the disintegrated vectors could not be purified by sucrose-gradient centrifugation because they were associated with serum proteins (Figure 2) . Also, preparation of EM replica was difficult in the presence of a high concentration of serum, thus, we were not able to provide the EM pictures of disassembled vectors.
EtBr intercalation assay
When EtBr is added to DNA in solution, it intercalates between the base pairs of DNA double helix, emitting an intense fluorescence signal at 618 nm when excited at 516 nm. If EtBr is added to a solution of DNA that is precomplexed with a cationic lipid or a cationic polymer, the fluorescence signal is reduced significantly. 21 With this assay, it has been shown that DNA can be displaced from lipoplexes by highly negatively charged molecules such as heparin and dextran sulfate. 22 In our study, we employed EtBr intercalation assay to investigate whether serum could also displace DNA from lipoplexes or lipopolyplexes. Figure 4a shows the fluorescence intensity of lipoplexes before and after exposure to mouse serum. DOTAP/DOPE liposomes formed more loose complexes with DNA as compared with DOTAP liposomes or DOTAP/cholesterol liposomes, ie much more DNA was accessible for interaction with EtBr. Figure 4a also shows that serum indeed caused displacement of DNA from lipoplexes. However, unlike the study of Xu and Szoka 22 in which release of DNA took place within 1 min after the addition of anionic molecules, serum-induced release of DNA from lipoplexes was a slower, time-dependent process. This might be due to the relatively low concentration of active, anionic molecules in the serum. Again, release of DNA was a more rapid process for DOPEcontaining lipoplexes than the other two formulations. Similar results were obtained when lipopolyplexes were used ( Figure 4b ).
It should be noted that the fluorescence intensity of plasmid DNA control started to decrease 1 h later following the exposure to serum. Therefore, the absolute numbers for DOPE formulations at later time-points could be underestimated due to the fact that DNA is more rapidly released from these formulations. PBS alone had no effect on the release of DNA from all lipidic vectors (data not shown).
FRET
FRET is a sensitive assay that can be used to monitor dynamic changes in the distance between two probes and has been widely used in the study of membrane fusion. 23 In this study, we used fluorescein-PE as a donor probe and Rh-PE as an acceptor probe and then followed the RET profile of lipidic vectors at different times after exposure to serum. As shown in Figure 5a , the fluorescein intensity gradually increased with time while the Rh intensity gradually decreased after the exposure of lipopolyplexes to mouse serum, suggesting that serum indeed caused separation of the two probes. Separation of the two probes over time suggests that serum causes disruption of vector bilayers. The effect of serum on the probe separation seems to be a general phenomenon: similar results were obtained when lipoplexes or when free liposomes were used (Figure 5b and c). Integrity of plasmid DNA after the exposure of lipidic vectors to mouse serum It was speculated that release of DNA from lipidic vectors by serum would render the DNA susceptible to degradation by nuclease in the serum. To confirm this possibility, DNA was extracted from lipidic vectors at different times after exposure to serum and its integrity was analyzed on a 1% agarose gel. The result is shown in Figure 6 . Plasmid DNA was poorly protected in lipoplexes that contained DOPE as a helper lipid. DNA degradation was seen after 1 and 2 h incubations with serum. There was no significant degradation of DNA in cholesterol-containing lipoplexes and lipoplexes that contained no helper lipid. The result of DNA protection assay is in agreement with results of the above studies which showed a rapid process of DNA release and of vector disintegration for DOPE-containing formulations. Similar results were obtained when lipopolyplexes were used (data not shown). Figure 7 shows the distribution in the lung of lipopolyplexes that contain different helper lipids. All of the formulations had a substantial amount of initial DNA accumulation in the lung, particularly the one that contained DOPE as a helper lipid. However, DNA formulated in DOPE formulations was rapidly removed from the lung while DNA formulated in other two formulations remained in the lung for a relatively longer period of time. Helper lipids did not affect the pattern of anatomic distribution of lipopolyplexes in the lung. Lipopolyplexes that contained different helper lipid were localized in the lung microvasculatures as confirmed using a confocal microscope (data not shown).
Effect of helper lipids on in vivo distribution of lipopolyplexes

Preincubation of lipidic vectors with serum inactivates their in vivo activity
The fact that serum could cause DNA release and vector disintegration suggests that serum itself could inactivate lipidic vectors in vivo. To test this hypothesis, lipidic vectors were preincubated with mouse serum in vitro for different periods of time and their in vivo distribution and transfection efficiency were evaluated, the results of which were also compared with that of untreated lipidic vectors. Figure 8 shows the in vivo distribution of serumtreated lipopolyplexes in the lung. Preincubation of lipopolyplexes with serum for 1 min did not affect their retention in the lung. However, prolonging the incubation to 30 min resulted in a significant decrease in the amount of lipopolyplexes that were retained in the lung, particularly those that contained DOPE as a helper lipid. Figure 9 shows gene expression in the lung 24 h after i.v. administration of lipopolyplexes that were preincubated with mouse serum for different periods of time. Pre-incubation with serum resulted in a time-dependent inactivation of lipidic vectors. Again, DOPE-containing lipopolyplexes were the formulation which gave the lowest level of gene expression at all time-points. Timedependent inactivation of lipidic vectors was also found when liposomes of other lipid compositions were used to prepare lipopolyplexes including lipofectin, lipofect-AMINE, DC-chol/DOPE and DOTMA liposomes (data not shown).
Discussion
We have shown in this study that the biophysical and biological properties of cationic lipidic vectors undergo dynamic changes after exposure to serum. The immediate effect of serum on lipidic vectors is vector aggregation. mechanism by which lung endothelial cells are transfected is still not clear at present. We have previously shown that serum-exposed, sucrose-gradient purified lipopolyplexes (which are negatively charged) can transfect lung as efficiently as the untreated lipopolyplexes, 20 suggesting that negatively charged particles are responsible for in vivo lipofection. We have further shown that in vivo lipofection of either lipoplexes or lipopolyplexes can be significantly enhanced by an acid-activated fusion peptide, 20 suggesting that endocytosis is a major mechanism for intravenous gene delivery. More study on the structure of serum-treated lipidic vectors and their interactions with cells in vitro might help us understand better the mechanism of in vivo lipofection.
It is generally believed that uptake of lipidic vectors by 
Figure 8 Pre-incubation with serum resulted in a decreased accumulation of lipopolyplexes in the lung. Lipopolyplexes containing different helper lipids were mixed with serum and the mixtures were then incubated at 37°C. At indicated times following incubation, serum-treated lipopolyplexes were i.v. injected into mice. Thirty minutes after injection, mice were killed, and then lungs were collected and assayed for radioactivity. The result was expressed as the percentage of injected dose per lung (n = 3). Plasmid DNA alone had a lung uptake of less than 5% of injected dose at all time-points.
Figure 9 Pre-incubation lipopolyplexes with serum resulted in a decreased in vivo gene expression. Lipopolyplexes of different lipid compositions were mixed with serum and the mixtures were then incubated at 37°C. At indicated times following incubation, serum-treated lipopolyplexes were i.v. injected into mice at a dose of 50 g DNA per mouse. Twenty-four hours following injection, mice were killed and lungs were collected. Lungs were homogenized in lysis buffer. The samples were centrifuged at 14 000 g for 10 min and the supernatant was assayed for luciferase activity and protein concentration, respectively. The result was expressed as relative light units per milligram of tissue proteins (n = 5).
from cationic lipidic vectors might be the result of the interaction of lipidic vectors with the highly negatively charged molecules in the serum as proposed by Xu and Szoka. 22 Plasmid DNA, when released from lipidic vectors, would be more susceptible to degradation by nuclease in the serum as shown in Figure 6 . Secondly, interactions of serum with cationic lipid vectors could gradually destabilize lipid vectors and eventually lead to vector disintegration. Those serum-modified vectors might gradually lose their ability to retain in the lung capillaries. This was supported by the observation that lipid vectors pretreated with serum in vitro had a much poorer distribution in the lung than untreated vectors, especially when lipid vectors were treated with serum for a relatively long period of time (Figure 8) . Accordingly, pretreatment of lipid vectors with serum gradually inactivated their in vivo transfection efficiency (Figure 9 ).
The effect of serum on cationic lipid vectors seems to be a general phenomenon. Similar results were obtained when either lipoplexes or lipopolyplexes were used. However, the rate of vector disintegration is greatly affected by lipid composition. Inclusion of DOPE as a helper lipid greatly accelerates the rate of vector disintegration. The rapid disintegration rate of DOPE-containing formulations might be due to the fluid nature of their bilayer. DOPE is a lipid which contains a relatively small head group and two bulky acyl chains which give the molecule an inverted cone shape. It is not favorable for the formation of a bilayer structure by itself under physiological conditions. 25 DOPE can form a bilayer with other lipids such as DOTAP, however, the resulting liposomes are relatively unstable and could undergo destabilization upon changes in pH, ion strength, temperature, etc. 25 Likewise, it is speculated that such unstable liposomes tend to form loose complexes with DNA in which DNA is poorly protected by cationic lipids. This was confirmed in EtBr binding assay; more DNA in the DOPE-containing lipoplexes was accessible for interaction with EtBr as compared with the other two formulations (Figure 4a) . Also, we have recently shown that DOPE-containing formulations recruit many more serum proteins than the formulations which either contain cholesterol as a helper lipid or contain no helper lipid. 20 The loose structure of DOPE-containing formulations together with their efficient interactions with serum proteins might be the major factors that lead to rapid vector disintegration and DNA release after exposure to serum.
In a simplified semiquantitative fashion, Table 1 16 Cholesterol-containing formulations have the best balance between the initial rapid aggregation and the subsequent slow disintegration, which leads to the highest level of gene expression.
It is not well understood at present how serum interacts with cationic lipidic vectors. The similarity between lipopolyplexes (or lipoplexes) and free liposomes in their interaction with serum ( Figures 1 and 5) suggests that the lipid bilayer is the primary target with which serum proteins interact. It is interesting to note that the disintegration rate of lipidic vectors is different when serum of different species is used. Disintegration of lipidic vectors is a much slower process in either fetal bovine serum or human serum (data not shown). This might be due to the difference in the amount of active components responsible for vector disintegration. So far, it is not known which serum proteins are the major components that are responsible for vector disintegration. Lipoproteins of low density are less likely to be the active components, because removal of these proteins from mouse serum by ultracentrifugation at 340 000 g for 24 h did not affect appreciably its interaction with lipidic vectors as shown in a turbidity study (data not shown). Identification of the active serum components will require further study.
Interactions of serum with anionic or neutral liposomes have been well documented. 26 While serum does not induce aggregation of those liposomes, it does cause their disintegration. It is not known at present how exactly cationic lipidic vectors differ from anionic or neutral liposomes in terms of interactions with serum. Nevertheless, the problem of inactivation by serum should also be considered when anionic or neutral lipidic vectors are employed for intravenous gene delivery.
In summary, we have shown in this study that cationic lipidic vectors undergo dynamic changes in their biophysical and biological properties after exposure to mouse serum. The results of this study explain why cationic lipidic vectors of different lipid compositions have a dramatic difference in their in vivo transfection efficiency. The results also suggest that the study on interactions of cationic lipidic vectors with serum may serve as a predictive model for in vivo performance of a lipidic vector. Finally, this study suggests that while current lipidic vectors are efficient in passive targeting of genes to lung endothelial cells, they are not suitable for targeted gene delivery to other tissues. Active, targeted gene delivery will require the development of a vehicle which has minimal interaction with serum and interacts with target cells in a tissue-specific fashion.
Materials and methods Purification and iodination of plasmid DNA Plasmid pCMVL, which contains the cDNA of firefly luciferase driven by a human cytomegalovirus immediate-early promoter, was amplified in DH5␣ strain of E. coli, isolated by alkaline lysis and purified by cesium chloride density gradient centrifugation. 27 Plasmid DNA was labeled with 125 I by using a published method 28 and purified by a spin column (Bio-Spin-P30). The purified 125 I-labeled DNA contained roughly equal amounts of supercoiled and relaxed closed circular DNA, as examined by gel electrophoresis and autoradiography.
Preparation of liposomes
Liposomes containing DOTAP alone or in a 1:1 molar ratio with cholesterol or DOPE were prepared as follows. The lipid mixture in chloroform was dried as a thin layer in a 100-ml round-bottomed flask which was further vacuum desiccated for 2 h. The lipid film was hydrated in 5% dextrose in water to give a final concentration of 10 mg DOTAP/ml. Preparation of small unilamellar vesicles (SUV) by extrusion was performed as follows: the lipid solution was briefly sonicated, followed by incubation at 50°C for 10 min and then sequentially extruded through polycarbonate membranes with the following pore sizes: 1.0, 0.6, 0.2 and 0.1 m. Similarly, liposomes containing 3 H-DPPC were prepared with a specific activity of 70 nCi/mol lipid.
Preparation of lipopolyplexes and lipoplexes
For preparation of lipopolyplexes, diluted DNA was added to the mixture of DOTAP/cholesterol liposomes and protamine at a final ratio of 0.6 g protamine/12 nmol DOTAP/g DNA. The mixture was incubated at room temperature for 10 min before use. Similarly, lipopolyplexes containing DOTAP liposomes or DOTAP/DOPE liposomes were prepared. For preparation of lipoplexes, DNA was added to liposomes and the mixture was incubated at room temperature for 10 min before use.
Sucrose density gradient centrifugation of lipopolyplexes before and after exposure to mouse serum Lipopolyplexes were prepared as described. Trace amounts of 125 I-labeled DNA and 3 H-labeled liposomes were included for quantification. Lipopolyplexes were mixed with 50% sucrose to a final concentration of 30% and the resulting mixture was loaded to a 4.5 ml ultracentrifuge tube. One milliliter of sucrose solutions of decreasing concentrations were then sequentially overlaid to form a 30-20-10-0% discontinuous gradient. The sample was centrifuged at 100 000 g at 20°C for 45 min in a SW50.1 rotor. Fractions were collected from top to bottom of the gradient. Both DNA and lipid contents were calculated for each fraction on the basis of radioactivity. To evaluate the effect of serum on the physical properties of lipopolyplexes, lipopolyplexes were mixed with mouse serum at a 1:2 (v/v) ratio. After incubation at 37°C for different times, the sucrose gradient profiles of serum-treated lipopolyplexes were similarly analyzed.
Freeze-fracture electron microscopy Lipopolyplexes before or 5 min after exposure to mouse serum were purified by sucrose density gradient centrifugation as described above. Lipopolyplex suspensions were placed between gold stubs and shock frozen by immersion in liquid nitrogen-cooled propane. Frozen samples were fractured using a hinged double replica device in a Balzars (Fü rstentum, Liechtenstein) freeze fracture unit model 301, at −150°C and 2 × 10 −6 Torr, shadowed at 45°with platinum-carbon, then at 90°with carbon. Replicas were immediately cleaned in deionized water, collected on 200 mesh copper grids and examined in a JEOL (Peabody, MA, USA) JEM 1210 transmission electron microscope operated at 80 kV.
Dynamic changes in the turbidity of lipidic vectors after exposure to mouse serum Lipopolyplexes, lipoplexes or free liposomes of different lipid compositions were mixed with mouse serum at a 1:2 (v/v) ratio and the mixtures were incubated at 37°C with gentle shaking. The absorbance of the mixtures at 600 nm was then recorded at different times with serum alone as a blank control.
EtBr intercalation assay
EtBr fluorescence at 618 nm was continuously monitored in a Perkin Elmer (Beaconsfield, Buckinghamshire, UK) luminescence spectrometer (excitation wavelength of 516 nm; 6 nm excitation and 10 nm emission slits) to measure the effect of serum on the extent of EtBr intercalation into DNA. Lipopolyplexes or lipoplexes of different lipid compositions were prepared as described above. Before or at different times after mixing with mouse serum, an aliquot of sample that contained 15 g of DNA was added to PBS (10 mm, pH 7.4) to a final volume of 3 ml. EtBr was then added to the mixture to a final concen-tration of 0.2 g/ml. The fluorescence signal usually stabilized in less than 3 min and was reported as the fraction of the maximum fluorescence I max that was obtained when EtBr was added to free plasmid DNA. Light scattering resulting from the addition of serum or liposomes caused less than a 5% change in the fluorescence signal.
Fluorescence resonance energy transfer (FRET)
FRET was employed in this study to investigate qualitatively whether serum could cause disruption of the bilayer of either lipopolyplexes or lipoplexes. Liposomes containing 0.5% (m/m) each of N-Rh-PE and fluorescein-PE were prepared and were then used to prepare either lipopolyplexes or lipoplexes as described above. At different times after incubation of lipidic vectors with mouse serum at 37°C, an aliquot of sample was added to PBS to a final volume of 3 ml and the emission spectra were recorded between 500 and 650 nm with excitation at 470 nm and 10 nm excitation and 6 nm emission slits. 29 Sensitivity of DNA to mouse serum Lipopolyplexes or lipoplexes of different lipid compositions were prepared as described. They were then mixed with mouse serum at a ratio of 1:2 (v/v) and the mixtures were incubated at 37°C with gentle shaking. At different times following incubation, plasmid DNA was extracted using QIAamp blood kit (QIAGEN, Valencia, CA, USA) and its integrity was analyzed on a 1% agarose gel with untreated plasmid DNA as a control.
In vivo distribution of lipopolyplexes
To study the effect of helper lipids on in vivo distribution of lipopolyplexes in mouse lung, 125 I-labeled lipopolyplexes that contained different helper lipids were administered into mice at a dose of 50 g DNA per mouse via tail vein in 300 l of 5% dextrose. At different times following injection, mice were killed. Lungs were collected, assayed for radioactivity and the result was expressed as the percentage of injected dose per lung. To investigate the effect of pre-incubation with serum on in vivo distribution of lipopolyplexes, lipopolyplexes were mixed with mouse serum and the mixtures were then incubated at 37°C for 1 or 30 min before injection. The in vivo distribution of lipopolyplexes were then similarly evaluated.
In a separate experiment, lipopolyplexes containing fluorescence (Cy3)-labeled DNA were injected i.v. into mice. Three minutes after injection, mice were killed and lungs were perfused intravascularly with 2% paraformaldehyde and 0.1% glutaraldehyde and inflated with this mixture to near total lung capacity. Cryosections were then prepared and the distribution of fluorescencelabeled DNA in lungs was observed with a confocal microscope.
Assay for luciferase activity Female CD-1 mice of 4-6 weeks of age were purchased from Charles River Laboratories (Wilmington, MA, USA) and housed in accordance with institutional guidelines. Individual mice in groups of five were injected i.v. with 50 g of DNA formulated in lipopolyplexes in a total volume of 200 l 5% w/v glucose. Twenty-four hours after injection, mice were bled from retro-orbital sinuses under anesthesia and were then killed by cervical dislocation. Lungs were collected and washed with cold saline twice. Lungs were homogenized with lysis buffer (0.05% Triton X-100, 2 mm EDTA, 0.1 m Tris, pH 7.8) using a tissue tearor (Biospec Products, Bartlesville, OK, USA). After two cycles of freeze and thaw, the homogenates were centrifuged at 14 000 g for 10 min at 4°C and 20 l of the supernatant was analyzed for luciferase activity using an Automated LB 953 luminometer equipped with an automated injector (Berthod, Bad Wildbad, Germany). The result was expressed as relative light units per milligram of tissue proteins. To evaluate the effect of pre-incubation with serum on in vivo activity of lipopolyplexes, lipopolyplexes were mixed with mouse serum and the mixtures were then incubated at 37°C for different periods of time before injection.
